- Risk factors of development of cysts and benign tumors of ovaries at women of genesial age
Risk factors of development of cysts and benign tumors of ovaries at women of genesial age
HEALTH OF WOMAN. 2019.6(142): 68–70; doi 10.15574/HW.2019.142.68
A.V. Boyko
Shupyk National Medical Academy of Postgraduate Education, Kiev
Sumy State University Medical University, MES of Ukraine
The objective: to increase forecasting effectiveness of cysts and benign tumors of ovaries at women of genesial age on the basis of establishment of major factors of risk.
Materials and methods. Was carried out the retrospective analysis of 500 operational protocols and the histological conclusions regarding compliance of the clinical and pathomorphologic diagnosis to the volume of expeditious treatment. All women were divided into the corresponding subgroups – cysts of ovaries – 284 women and benign tumors of ovaries – 216 patients. All-clinical methods researches were conducted according to the offered card of WHO (2015), including data on the genesial anamnesis, existence of the gynecologic and extragenital diseases, carried-out therapy, the general objective inspection, special gynecologic inspection and laboratory methods of research.
Results. In group of high risk on case rate cysts and benign tumors of ovaries treat patients with high frequency benign diseases of uterus cervix(OR=7.32) and body of the womb (OR=6.23), sterility (OR=2.77), inflammatory diseases of organs of small basin (OR=2.39), with disturbances of menstrual cycle (OR=2.3), with high frequency anginas and virus infections (OR=6.55), diseases of thyroid gland (OR=6.4), liver (OR=4.59) and the top respiratory tracts (OR=4.32), not using rational contraception (OR=2.09).
Conclusion. The received results needs to be considered when forecasting cysts and benign tumors of ovaries at women of genesial age.
Key words: cysts and benign tumors of ovaries, genesial age, risk factors.
REFERENCES
1. Zvarych LI, Lutsenko NS, Shapoval OS, 2015. Chastota funktsionalnykh kist yaiechnykiv u zhinok reproduktyvnoho viku v strukturi hinekolohichnoi patolohii. Suchasni medychni tekhnolohii 2;3:79–83.
2. Kuznetsova EP. 2010. Sovremennyie predstavleniya ob etiologii i patogeneze opuholevidnyih obrazovaniy i dobrokachestvennyih opuholey yaichnikov. Saratovskiy nauchno-meditsinskiy zhurnal 6;3: 552–558.
3. Reznichenko GI, Shapoval OS. 2015. Osobennosti realizatsii reproduktivnoy funktsii u zhenschin s dobrokachestvennyimi opuholevidnyimi obrazovaniyami yaichnikov. Zdorove zhenschiny 2(98): 104–107.
4. Serebrennikova KG, Kuznetsova EP, Halilov RZ. 2010. Faktoryi riska razvitiya opuholevidnyih obrazovaniy i dobrokachestvennyih opuholey yaichnikov. Uralskiy meditsinskiy zhurnal 6 (71):111–115.
5. Shapoval OS. 2016. Kisty yaiechnykiv. Analiz struktury patolohii u zhinok reproduktyvnoho viku. Scientific journal «ScienceRise: Medical Science» 9(5): 75–79.
6. Shapoval O. 2016. Clinical and Diagnostic Parallels, Therapeutical Strategies in Benign Ovarian Tumor-Like Formations. The Science Advanced 02: DOI: 10.15550/ASJ.2016.02.027 : 27–33. https://doi.org/10.15550/ASJ.2016.02.027
7. Vorontsova LL, Shapoval OS. 2015. Pathogenetic rationale for the use of immunomodulating and systemic enzyme therapy in treatment of nulliparous women with endometriod ovary tumors. Journal of Education, Health and Sport 1;5:75–86.
